How oftenOnce a day, sometimes split into two doses
Half-lifeUnknown in humans
Vial sizes—
The simple version
What it does
It blocks an enzyme linked to fat storage, which cut fat in obese mice.
How people take it
People typically take 50–150 mg by mouth once a day.
Know this
It has never been tested in people, so its safety and right dose are unknown.
What it is
5-Amino-1MQ is a small molecule, not a peptide, so it works more like a regular pill. University researchers in Texas made it as a lab tool to block an enzyme called NNMT. It gets grouped with peptides because the same people use it, and it's usually taken as a capsule.
How it works
NNMT is an enzyme that works overtime in the fat cells of people and animals with obesity, and it uses up raw material cells need to make energy. Blocking it slowed fat storage in lab dishes. In obese mice, it led to less fat and lower weight even though they didn't eat less.
What people use it for
Fat loss
Metabolic health (how your body uses energy)
Muscle function with aging (mouse data only)
The evidence
Mostly animal studies
So far it's only been tested in mice and lab dishes. In a key 2018 study, obese mice lost weight and fat and had lower cholesterol without eating less, and later mouse studies found similar results, plus better muscle function in old mice. No human trial has been published, so nobody knows the right dose, how well a pill is absorbed in people, or what long-term use does.
Why: These amounts come from what people commonly use, not from human studies. Taking breaks is a habit borrowed from other supplements; no data shows it's needed or helpful.
Start at the low end, and change one thing at a time. If you take medication or have a health condition, check with a doctor first.
No. It's a small molecule, much smaller than a peptide. That's why it can be taken by mouth.
Has it been tested in humans?
No published human trials as of October 2026. Everything we know comes from mice and lab dishes.
Will it make me lose weight without eating less?
That's what happened in obese mice. Whether people respond the same way, and at what dose, is unknown.
Sources
Neelakantan H, et al. Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice. Biochem Pharmacol. 2018;147:141-152. PubMed 29155147
Kraus D, et al. Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity. Nature. 2014;508(7495):258-62. PubMed 24717514
Sampson CM, et al. Combined nicotinamide N-methyltransferase inhibition and reduced-calorie diet normalizes body composition and enhances metabolic benefits in obese mice. Sci Rep. 2021;11(1):5637. PubMed 33707534
Dimet-Wiley AL, et al. Nicotinamide N-methyltransferase inhibition mimics and boosts exercise-mediated improvements in muscle function in aged mice. Sci Rep. 2024;14(1):15554. PubMed 38969654